Lenvatinib/Pembro Combo for Advanced Anaplastic Thyroid Cancer
The nonchemotherapy combination has shown durable responses in patients with metastatic anaplastic thyroid cancer that has progressed on chemotherapy.
Source: medscape.com
📰 Endocrinology Program News
Endocrinology Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Endocrinology Program. Real-time updates on events, politics, business and more.